Medicare and private health insurers said they were unlikely to change coverage of breast cancer screenings after new guidelines recommended that women wait longer to have mammograms and have fewer of them.

Call it death panel redux. It did not take long for Republicans in Congress to start arguing on Tuesday that a federal task force's new recommendations on breast cancer screening had confirmed the worst fears of people who oppose a government role in medical decision making.